RCM
BCYC

RA Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

RA Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,093,477
Closed -$9.28M – 68
2025
Q1 		$9.28M Hold
1,093,477
– – 0.16% 64
2024
Q4 		$15.3M Sell
1,093,477
-1,159,523
-51% -$24.9M 0.2% 66
2024
Q3 		$51M Hold
2,253,000
– – 0.59% 37
2024
Q2 		$45.6M Buy
2,253,000
+1,453,000
+182% +$32.8M 0.6% 41
2024
Q1 		$19.9M Hold
800,000
– – 0.25% 58
2023
Q4 		$14.5M Hold
800,000
– – 0.23% 53
2023
Q3 		$16.1M Buy
+800,000
New +$18.3M 0.32% 50

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

RA Capital Management's BCYC Position: Q2 2025 in Review

RA Capital Management sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 1,093,477 shares — an estimated $9.28M sold.

RA Capital Management first reported a position in BCYC in Q3 2023 and held it in 7 quarters. The position peaked at $51M in Q3 2024. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

  • RA Capital Management reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
  • RA Capital Management sold 1,093,477 Bicycle Therapeutics shares in Q2 2025, an estimated $9.28M.
  • RA Capital Management first reported a position in Bicycle Therapeutics in Q3 2023 and held it in 7 quarters.
  • RA Capital Management's Bicycle Therapeutics position peaked at $51M in Q3 2024.
  • 110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on RA Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.